Because TRPV1 has shown strong associations with the pathogenesis of neurodegenerative diseases, TRPV1 agonists and antagonists are becoming promising therapeutic targets (Figure 3, Table 2). This evidence concerns the gene TRPV1 and neurodegenerative disease.